|
197 One in five online pharmacies operates from the UK There are 570 websites selling medicines hosted in the UK, according to US research. The research does not indicate how many of them are operated by legitimate pharmacies or how many of them are illegal
PJ 2007;279:197
Full Text
197 CD destruction rules change Accountable officers, responsible for monitoring and managing the use of Controlled Drugs within an NHS organisation, can now authorise people to witness the destruction of CDs, following amendments to the Misuse of Drugs Regulations 2001
PJ 2007;279:197
Full Text
197 Pharmacy vacancies fall The number of unfilled pharmacy jobs in NHS organisations in England has fallen
PJ 2007;279:197
Full Text
197 Scotland funds error studies Scotland is to spend £2.5m on research aimed at finding out why mistakes are made when patients are treated in hospital
PJ 2007;279:197
Full Text
198 Restricted approval of rituximab and adalimumab Arthritis treatments rituximab (Mabthera) and adalimumab (Humira) have been approved for use in England and Wales by the National Institute for Health and Clinical Excellence, with restricions, in separate technology appraisals
PJ 2007;279:198
Full Text
198 NICE issues guidance on managing urinary tract infection in children Children
from three months of age with acute pyelonephritis (upper urinary tract infection)
should be treated with an oral antibiotic with low resistance patterns, such
as a cephalosporin or co-amoxiclav, for seven to 10 days, the National Institute
for Health and Clinical Excellence sets out in a new clinical guideline, developed
in conjunction with the National Collaborating Centre for Women’s and Children’s
Health
PJ 2007;279:198
Full Text
198 NICE allows MS drug for specific patients Natalizumab (Tysabri) has been recommended by the National Institute for Health and Clinical Excellence for the treatment of selected multiple sclerosis (MS) patients in its latest round of appraisals
PJ 2007;279:198
Full Text
198 Emtricitabine and tenofovir/emtricitabine approved for Wales Emtricitabine
(Emtriva) and tenofovir/ emtricitabine (Truvada) have been accepted for use in
the NHS in Wales, following ministerial approval of the recommendations made
by the All-Wales Medicines Strategy Group
PJ 2007;279:198
Full Text
198 Pemetrexed rejected by NICE for non-small
cell lung cancer The National Institute for Health
and Clinical Excellence has rejected antifolate agent pemetrexed (Alimta)
PJ 2007;279:198
Full Text
199 EU prescriptions could
in future be valid in the UK Legislation that controls the prescribing and
dispensing of medicines in the UK and defines what information a prescription
must contain in order to be valid is about to become fragmented as a result of
intervention by the European Commission
PJ 2007;279:199
Full Text
199 Organisations consulted about proposed premises fee increase The Department of Health is consulting pharmacy organisations about the Royal Pharmaceutical Society’s proposed 56 per cent increase in premises fees
PJ 2007;279:199
Full Text
199 PDA and IPF urge Society to ask Government
for financial support The Pharmacists’ Defence Association and the
Independent Pharmacy Federation this week added their voices to others complaining
about the Royal Pharmaceutical Society’s proposed hike in pharmacists’ retention
fees
PJ 2007;279:199
Full Text
200 Pharmacists must learn to assess mental health needs of old people All pharmacists should receive training in the
assessment and care of old people with mental health needs, an Age Concern report recommends
PJ 2007;279:200
Full Text
200 Palliative care funds for Scotland announced Funding for palliative care model schemes
in Scotland was announced this week by the
Scottish Executive
PJ 2007;279:200
Full Text
200 England's medicines costs rise as prescriptions increase Medicines costs in England increased by 3.3
per cent in 2006, driven by a 4.4 per cent increase
in prescribing by GPs
PJ 2007;279:200
Full Text
200 Scottish Executive keeps community services for long-term conditions in its sights Developing
community-based services for people with long-term conditions will remain
a central aim of the Scottish
Government’s future health policy
PJ 2007;279:200
Full Text
200 Sodium cromoglicate Galpharm has asked the Medicines and
Healthcare products Regulatory Agency to
reclassify sodium cromoglicate 2 per cent
eye-drops from a pharmacy medicine to
a general sale list medicine
PJ 2007;279:200
Full Text
200 PHS legislation update Updated legislation for the public health
service, part of the community
pharmacy contract in Scotland, was
published last week
PJ 2007;279:200
Full Text |
The
Pharmaceutical Journal